News >

West Cancer Center Faculty Walk Through Ongoing Breast Cancer Research Efforts

Kristi Rosa
Published: Wednesday, Nov 27, 2019

At the 2019 OncLive®  State of the Science Summit on Breast Cancer, experts from West Cancer Center highlighted the exciting research being conducted at their institution.

 
Lee Schwartzberg, MD, FACP, Executive Director and Medical Director, West Cancer Center; Chief and Professor of Medicine, Division of Hematology/Oncology, University of Tennessee Health Science Center; Chief Medical Officer, OneOncology

Lee Schwartzberg, MD, FACP

Lee Schwartzberg, MD, FACP: Executive Director and Medical Director, West Cancer Center; Chief and Professor of Medicine, Division of Hematology/Oncology, University of Tennessee Health Science Center; Chief Medical Officer, OneOncology

“We are doing a number of trials at West Cancer Center with immunotherapy. One interesting trial is examining an oral taxane called tesetaxel, which is given once every 3 weeks. A registration trial (NCT03858972) that has just completed accrual [is examining tesetaxel] in combination with capecitabine versus capecitabine alone in [patients with] hormone receptor–positive, HER2-negative breast cancer. We should see the results of that study in 2020.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x